Key points are not available for this paper at this time.
MnO x /C and Me-MnO x /C (Me = Ni, Mg) electrocatalysts prepared by chemical deposition of manganese oxide nanoparticles on carbon have been characterized by Transmission Electron Microscopy (TEM), X-ray Diffraction (XRD), and chemical analysis. Their Oxygen Reduction Reaction (ORR) kinetics and mechanism have been investigated in alkaline KOH solutions by using the Rotating Disk Electrode (RDE) and the Rotating Ring-Disk Electrode (RRDE) setups. Doping the MnO x /C nanoparticles with nickel or magnesium divalent cations can considerably improve their oxygen reduction activity. As a result, the Me-MnO x /C electrocatalysts exhibit ORR specific or mass activities close to the benchmark 10 wt % Pt/C from E-TEK. At low ORR current densities, the undoped MnO x /C electrocatalyst displays a reaction order with respect to P O 2 and OH - of 1 and −0.5, respectively, while ∂ E /∂log i is ca. −59 mV dec -1 . The ORR reaction order toward OH - is unchanged with the magnesium doping, while it becomes −2 with the nickel doping. RRDE data show that doping the MnO x /C electrocatalysts directs the ORR toward the four-electron pathway. The first electrochemical step of the 4-electron ORR mechanism is probably the quasiequilibrium proton insertion process into MnO 2 leading to MnOOH, while the second electron transfer, consisting of the O 2,ads species electrosplitting, yielding O ads and hydroxide anion, is rate determining. The presence of the doping metal cations may stabilize the intermediate Mn III /Mn IV species, which assist this second charge transfer to oxygen adatoms. As a result, the ORR rate is enhanced for the Me-MnO x /C electrocatalysts: they exhibit remarkable ORR catalytic activity and yield quantitative formation of OH - (selectivity toward the 4-electron pathway).
Roche et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: